Recent Quotes
My Watchlist
Indicators
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Chartmill

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
MACOM Technology Solutions Holdings (NASDAQ:MTSI) Reports Q4 2025 Earnings and Strong Forward Guidance
Via Chartmill
Tickers MTSI
Papa John's International Inc (NASDAQ:PZZA) Stock Falls on Q3 Earnings Miss and Lowered Guidance
Via Chartmill
Topics Earnings
Tickers PZZA
Kimbell Royalty Partners LP (NYSE:KRP) Reports Q3 2025 Earnings Beat Amid Slight Revenue Miss
Via Chartmill
Topics Earnings
Tickers KRP
CARS.COM INC (NYSE:CARS) Q3 2025 Earnings: EPS Beats by 200% as Profitability Soars
Via Chartmill
Tickers CARS
Under Armour (NYSE:UAA) Reports Mixed Q2 Fiscal 2026 Results as Stock Dips Despite Earnings Beat
Via Chartmill
Tickers UAA
LSI Industries Inc (NASDAQ:LYTS) Reports Q1 FY2026 Earnings Miss Despite Strong Revenue Beat
Via Chartmill
Topics Earnings
Tickers LYTS
Appian Corp-A (NASDAQ:APPN) Surpasses Q3 2025 Earnings and Revenue Estimates
Via Chartmill
Tickers APPN
ConocoPhillips (NYSE:COP) Tops Q3 2025 Earnings and Revenue Estimates
Via Chartmill
Tickers COP
Stay updated with the stocks that are on the move in today's pre-market session.
Via Chartmill
Tickers ACVA ALTO ARQ ASPN ASTI BHF
Monte Rosa Therapeutics Inc (NASDAQ:GLUE) Q3 2025 Earnings Beat Estimates, Stock Rises
Via Chartmill
Topics Earnings
Tickers GLUE
VIATRIS INC (NASDAQ:VTRS) Q3 2025 Earnings Beat Expectations
Via Chartmill
Topics Earnings
Tickers VTRS
CULLINAN THERAPEUTICS INC (NASDAQ:CGEM) Q3 2025 Earnings Beat Estimates and Announces Strategic Pipeline Refocus
Via Chartmill
Topics Earnings
Tickers CGEM
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) Q3 2025 Earnings Surpass Expectations, Fueling Pre-Market Rally
Via Chartmill
Tickers LXRX
Rapport Therapeutics Inc (NASDAQ:RAPP) Reports Q3 2025 Earnings Beat and Positive Phase 2a Seizure Data
Via Chartmill
Topics Earnings
Tickers RAPP
Moderna Inc (NASDAQ:MRNA) Reports Q3 2025 Revenue Beat and Narrower-Than-Expected Loss
Via Chartmill
Topics Earnings
Tickers MRNA
Cummins Inc (NYSE:CMI) Q3 Earnings Beat Estimates Amidst Strategic Charges
Via Chartmill
Topics Earnings Energy
Tickers CMI
NOVA LTD (NASDAQ:NVMI) Reports Mixed Q3 2025 Results, Shares Tumble on Revenue Miss
Via Chartmill
Tickers NVMI
Rockwell Automation Inc (NYSE:ROK) Surpasses Q4 Earnings and Revenue Estimates, Stock Jumps
Via Chartmill
Tickers ROK
Core Natural Resources Inc (NYSE:CNR) Posts Strong Q3 2025 Earnings Beat
Via Chartmill
Topics Earnings
Tickers CNR
Parker Hannifin (NYSE:PH) Q1 2026 Earnings Beat Estimates and Raise Full-Year Guidance
Via Chartmill
Topics Earnings
Tickers PH
REGENXBIO INC (NASDAQ:RGNX) Tops Q3 2025 Estimates, Shares Rise on Strong Results and Pipeline Progress
Via Chartmill
Tickers RGNX
XERIS BIOPHARMA HOLDINGS INC (NASDAQ:XERS) Posts Record Q3 2025 Revenue but Misses Analyst Estimates
Via Chartmill
Tickers XERS
BARCLAYS PLC-SPONS ADR (NYSE:BCS) Shows Strong Technicals and Bullish Setup for Potential Breakout
Via Chartmill
Tickers BCS
Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance
Via Chartmill
Tickers COLL
Novo Nordisk A/S-Spons ADR (NYSE:NVO) Embodies Affordable Growth Strategy
Via Chartmill
Tickers NVO
X Financial-ADR (NYSE:XYF) Presents a Compelling Case for Peter Lynch Investors
Via Chartmill
Tickers XYF
EOG RESOURCES INC (NYSE:EOG) Embodies Peter Lynch's GARP Investment Philosophy
Via Chartmill
Tickers EOG
AVEANNA HEALTHCARE HOLDINGS (NASDAQ:AVAH) Beats Q3 2025 Estimates and Raises Full-Year Guidance
Via Chartmill
Tickers AVAH
CLEAR Secure Inc (NYSE:YOU) Q3 2025 Earnings: Revenue and EPS Beat Estimates, Shares Rally
Via Chartmill
Topics Earnings
Tickers YOU
Privia Health Group Inc (NASDAQ:PRVA) Reports Mixed Q3 2025 Results, Raises Full-Year Guidance
Via Chartmill
Topics Earnings
Tickers PRVA
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.